Micrima: Developing technology for breast cancer screening
A new breast cancer screening method in the future.
Micrima is a Bristol based diagnostic imaging company founded in 2006. Micrima has developed the MARIA™ breast cancer screening system. This breast imaging system uses harmless radio-waves to detect breast cancer, unlike mammography that uses ionising radiation. MARIA also requires no breast compression so is painless for women. It is a whole breast method of imaging compared to some modalities that use a handheld probe. With a handheld system, the operator needs to know where to look for a lesion. It has proven more effective than current imaging methods, particularly in dense tissue. MARIA has been trialled in over 400 women in the United Kingdom. Further trials are taking place at leading European centres. Currently, MARIA™ is being used in symptomatic clinics, it is hoped eventually this will be a viable alternative to mammography in breast screening.
Clinical poster and presentation
Micrima is pleased to have had a poster at the EUSOBI scientific meeting this year and the …
Micrima’s latest grant funded project
Reaching a final diagnosis for Breast cancer is a complex process with many steps. Despite the diagnostic performance …